nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A contemporary population-based analysis of the incidence, cost, and outcomes of postoperative delirium following major urologic cancer surgeries
|
Ha, Albert |
|
2018 |
36 |
7 |
p. 341.e15-341.e22 |
artikel |
2 |
Commentary on “A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy—A single-institution experience.”
|
Yang, GL |
|
2018 |
36 |
7 |
p. 346-347 |
artikel |
3 |
Commentary on “Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.”
|
Soave, A |
|
2018 |
36 |
7 |
p. 347-348 |
artikel |
4 |
Commentary on “DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma.”
|
Teo, MY |
|
2018 |
36 |
7 |
p. 345-346 |
artikel |
5 |
Commentary on “Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy.”
|
Thomas, DE |
|
2018 |
36 |
7 |
p. 345 |
artikel |
6 |
Cover 2 -- Masthead
|
|
|
2018 |
36 |
7 |
p. IFC |
artikel |
7 |
Decision analysis defining optimal management of clinical stage 1 high-risk nonseminomatous germ cell testicular cancer with lymphovascular invasion
|
Avulova, Svetlana |
|
2018 |
36 |
7 |
p. 342.e1-342.e6 |
artikel |
8 |
Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study
|
Guo, Run-Qi |
|
2018 |
36 |
7 |
p. 342.e15-342.e23 |
artikel |
9 |
Editorial Board
|
|
|
2018 |
36 |
7 |
p. i |
artikel |
10 |
Establishment of the optimal follow-up schedule after radical prostatectomy
|
Matsumoto, Kazuhiro |
|
2018 |
36 |
7 |
p. 341.e9-341.e14 |
artikel |
11 |
Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study
|
Sathianathen, Niranjan J. |
|
2018 |
36 |
7 |
p. 338.e13-338.e17 |
artikel |
12 |
Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis
|
Sidana, Abhinav |
|
2018 |
36 |
7 |
p. 341.e1-341.e7 |
artikel |
13 |
Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort
|
Marra, Giancarlo |
|
2018 |
36 |
7 |
p. 339.e1-339.e8 |
artikel |
14 |
Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy
|
Winters, Brian R. |
|
2018 |
36 |
7 |
p. 342.e7-342.e14 |
artikel |
15 |
Metabolic changes in bladder cancer
|
Woolbright, Benjamin L. |
|
2018 |
36 |
7 |
p. 327-337 |
artikel |
16 |
Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial
|
Gelfond, Jonathan |
|
2018 |
36 |
7 |
p. 340.e1-340.e6 |
artikel |
17 |
Monopolar vs. bipolar transurethral resection for non–muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial
|
Liem, Esmee I.M.L. |
|
2018 |
36 |
7 |
p. 338.e1-338.e11 |
artikel |
18 |
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma
|
Singla, Nirmish |
|
2018 |
36 |
7 |
p. 343.e1-343.e8 |
artikel |
19 |
Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival
|
Teishima, Jun |
|
2018 |
36 |
7 |
p. 339.e9-339.e15 |
artikel |
20 |
Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis
|
Onukwugha, Eberechukwu |
|
2018 |
36 |
7 |
p. 340.e23-340.e31 |
artikel |
21 |
PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma
|
Wang, Keshan |
|
2018 |
36 |
7 |
p. 343.e9-343.e19 |
artikel |
22 |
Predicting morbidity after robotic partial nephrectomy: The effect of tumor, environment, and patient-related factors
|
Khene, Zine‐Eddine |
|
2018 |
36 |
7 |
p. 338.e19-338.e26 |
artikel |
23 |
Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis
|
Sciarra, Alessandro |
|
2018 |
36 |
7 |
p. 340.e7-340.e21 |
artikel |
24 |
Stauffer’s syndrome: A comprehensive review and proposed updated diagnostic criteria
|
Fontes-Sousa, Mário |
|
2018 |
36 |
7 |
p. 321-326 |
artikel |
25 |
Survey Section Editorial Board
|
|
|
2018 |
36 |
7 |
p. 344 |
artikel |
26 |
Table of Contents
|
|
|
2018 |
36 |
7 |
p. ii-iii |
artikel |
27 |
The evolution of bladder cancer genomics: What have we learned and how can we use it?
|
Audenet, François |
|
2018 |
36 |
7 |
p. 313-320 |
artikel |
28 |
What is the hospital volume threshold to optimize inpatient complication rate after partial nephrectomy?
|
Arora, Sohrab |
|
2018 |
36 |
7 |
p. 339.e17-339.e23 |
artikel |